Bortezomib to Treat Significant Complication of HSCT
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the safety and effectiveness of a drug called
Bortezomib for the treatment of low blood cell counts after bone marrow transplant.